Emergent BioSolutions, Inc. (EBS)
10.86
-0.13
(-1.18%)
USD |
NYSE |
Jan 20, 11:12
Emergent BioSolutions Market Cap: 570.37M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 131.85B |
| Eli Lilly & Co. | 932.47B |
| Penumbra, Inc. | 13.87B |
| Disc Medicine, Inc. | 2.714B |
| Black Diamond Therapeutics, Inc. | 140.16M |
Market Cap Related Metrics
| PE Ratio | 8.393 |
| PS Ratio | 0.7647 |
| Price to Book Value | 0.9792 |
| Price to Free Cash Flow | 430.91 |
| Price | 10.86 |
| Earnings Yield | 11.92% |
| Operating PE Ratio | 5.201 |
| Normalized PE Ratio | 8.602 |